Clinical trial
Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients
NCT02255357 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- February 14, 2018
- Enrollment
- 43 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cocaine dependence